Private company
SynBio
SynBio is a long-term project started in 2011 with the goal of creating innovative medicines, including what are known as Biobetters. This project is a collaborative effort of several Russian and international pharmaceutical companies.3 It is headquartered in Moscow.1 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
See how the biggest companies compare on our leaderboards
SynBio is a long-term project started in 2011 with the goal of creating innovative medicines, including what are known as Biobetters. This project is a collaborative effort of several Russian and international pharmaceutical companies.3
Subsidiaries and ownership
Owners
From Wikidata.1
Timeline
- 2011Founded Founded1
SEC filer profile
How SynBio is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
Links
- WikipediaSynBio
- WikidataQ7661923
- SEC EDGARCIK 1711456
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataSynBio on Wikidata
- 2SEC EDGARSynBio filings on SEC EDGAR
- 3WikipediaSynBio on Wikipedia